Charles River Laboratories Intl
(CRL)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | CRL | RVTY | AVTR | ||
| Company | Charles River Laboratories Intl | Revvity Inc | Avantor Inc | ||
| Price Information | |||||
| Exchange | NYSE | NYSE | NYSE | ||
| Open | 182.00 | 103.46 | 11.34 | ||
| High | 184.45 | 106.55 | 11.34 | ||
| Low | 178.27 | 102.80 | 11.04 | ||
| Latest | 181.24 | 104.75 | 11.16 | ||
| Change | -4.46 | +1.93 | -0.07 | ||
| % Change | -2.40% | +1.88% | -0.62% | ||
| Volume | 1,055,300 | 1,282,300 | 28,623,500 | ||
| 20-Day Average Volume | 730,855 | 1,717,840 | 13,890,930 | ||
| Previous Close | 185.70 | 102.82 | 11.23 | ||
| Industry | Medical Services | Medical Services | Medical Services | ||
| Has Options | Yes | Yes | Yes | ||
| Technicals | |||||
| 20-Day Moving Average | 210.21 | 109.54 | 11.55 | ||
| 20-Day Raw Stochastic | 5.87% | 30.90% | 21.97% | ||
| 20-Day Relative Strength | 36.46 | 49.81 | 45.56 | ||
| Weighted Alpha | +28.88 | +0.16 | -32.06 | ||
| Today's Opinion | 40% Buy | 72% Buy | 88% Sell | ||
| Previous Opinion | 40% Buy | 56% Buy | 88% Sell | ||
| Last Month's Opinion | 100% Buy | 88% Buy | 40% Sell | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | -10.01% since 02/03/26 | +3.58% since 02/03/26 | +2.86% since 02/03/26 | ||
| Low | 178.27 on 02/10/26 | 98.69 on 02/06/26 | 10.67 on 02/05/26 | ||
| High | 203.74 on 02/04/26 | 106.54 on 02/10/26 | 11.35 on 02/09/26 | ||
| 1-Month | |||||
| %Chg | -17.96% since 01/09/26 | +0.31% since 01/09/26 | -10.07% since 01/09/26 | ||
| Low | 178.27 on 02/10/26 | 98.69 on 02/06/26 | 10.67 on 02/05/26 | ||
| High | 228.88 on 01/13/26 | 118.30 on 01/22/26 | 12.90 on 01/14/26 | ||
| 3-Month | |||||
| %Chg | +7.26% since 11/10/25 | +13.51% since 11/10/25 | -2.96% since 11/10/25 | ||
| Low | 156.72 on 11/19/25 | 89.65 on 11/18/25 | 10.62 on 12/09/25 | ||
| High | 228.88 on 01/13/26 | 118.30 on 01/22/26 | 12.90 on 01/14/26 | ||
| 6-Month | |||||
| %Chg | +21.85% since 08/08/25 | +20.62% since 08/08/25 | -2.96% since 08/08/25 | ||
| Low | 144.26 on 09/25/25 | 81.36 on 09/04/25 | 10.62 on 12/09/25 | ||
| High | 228.88 on 01/13/26 | 118.30 on 01/22/26 | 15.93 on 10/21/25 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 9,139,226 | 11,657,320 | 7,656,782 | ||
| Shares Outstanding, K | 49,215 | 113,376 | 681,815 | ||
| Annual Sales | 4,049,990,000 | 2,856,050,000 | 6,783,600,000 | ||
| Annual Net Income | 22,200,000 | 241,200,000 | 711,500,000 | ||
| Last Quarter Sales | 1,004,850,000 | 772,060,000 | 1,623,800,000 | ||
| Last Quarter Net Income | 54,420,000 | 98,360,000 | -711,800,000 | ||
| 60-Month Beta | 1.63 | 1.06 | 0.94 | ||
| Per-Share Information | |||||
| Most Recent Earnings | 2.43 on 11/05/25 | 1.70 on 02/02/26 | 0.22 on 10/29/25 | ||
| Latest Earnings Date | 02/18/26 | 04/27/26 | 02/11/26 | ||
| Most Recent Dividend | N/A | 0.070 on 01/16/26 | N/A | ||
| Next Ex-Dividends Date | N/A | 04/17/26 | N/A | ||
| Ratios | |||||
| Price/Earnings ttm | 17.93 | 20.04 | 11.73 | ||